Related Experiment Video
Updated: May 10, 2026

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
[Exemples of tumor markers and their clinical utility]
Apostolos Sarivalasis1, Marie-Laure Amram, Pierre-Yves Dietrich
1Service d'oncologie, HUG, Genève 14. apostolos.sarivalasis@hcuge.ch
Abstract:
The burden of the decisions related to cancer management is the reason why doctors are trying to use the best indicators to manage doubt and uncertainty, as well as to improve treatment targeting. These indicators are called tumor markers. They may assist in the diagnostic process and help in establishing the prognosis. They may be used for screening an asymptomatic disease, early detection of recurrent disease and mainly follow-up during cancer therapies. The better understanding of carcinogenesis coupled to technical improvements led to the discovery of new markers. They target cellular or genetic abnormalities and revisit classic cancer classification while some predict disease response to targeted therapies. This is the era of personalized oncology.
